Medtronic Kanghui Unveils Two Innovative Technologies at CIIE to Advance Clinical-Industry Synergy

China Finance and Economics Network, November 7th: As a "full-time participant" for eight consecutive years, Medtronic Kanghui showcased AiBLE^™The Intelligent Innovation Ecosystem Debuts at the 8th China International Import Expo, with the theme "Intelligence Gathering · New Ecosystem," showcasing collectively since 2023 AiBLE.^™Since its debut at the CIIE, Genlight Neurotech has showcased its latest achievements in digital intelligence innovation, industrial collaboration, and global sharing.

"The CIIE witnessed AiBLE"^™The growth and evolution of the intelligent innovation ecosystem have also witnessed the steps of Medtronic Kanghui accompanying China's medical innovation forward. "Medtronic Vice President and General Manager of China Orthopedics and Neurosurgery Business, Jing Yu, stated that in China, Medtronic Kanghui relies on AiBLE.^™Ecosystem continues to drive the implementation of digital intelligence innovation results, collaborates with partners to explore the technological frontier, and accelerates the digital transformation of orthopedics and neurosurgery.

This year, AiBLE^™Multiple star products from the ShuZhi Ecosystem family have "collectively returned," including the Mazor that was first exhibited at last year's CIIE.^™ XC Spine Surgery Robot, NIM-Eclipse^™Intraoperative Neuromonitoring System, and Qíng Háng^™EngineNav^™Spine surgical navigation systems and other representatives of new domestic forces. Thanks to the powerful "spillover effect" of the CIIE, these innovative achievements have successively completed commercialization and clinical implementation over the past year, realizing a leap from the "CIIE booth" to the "operating table."

At this year's CIIE, Medtronic Kanghui, in collaboration with Jinhai Medical and GenLight, released two innovative technologies: "Minimally Invasive Spinal Endoscopy under Navigation" and "Robot-Guided Laser Ablation Minimally Invasive Technology." These aim to create product-compatible innovative procedures for clinical scenarios and promote the collaborative advancement of clinical practices and industry.

Among them, Medtronic Kanghui and Jinhai Medical jointly released the "Minimally Invasive Spinal Endoscopy Technology under Navigation," combining Jinhai Medical's innovative spinal endoscopy solutions with Medtronic Kanghui's locally developed Qihang system.^™EngineNav^™Deep Integration and Joint Innovation of Spinal Surgical Navigation Systems Promote the Wide Application of Endoscopic Technology in Spinal Surgery.

Chen Guobao, Chairman of the Board of Directors of Jinhai Medical Technology Co., Ltd., stated that endoscopic technology plays a significant role in the minimally invasive development of spinal surgeries, and the demand for minimally invasive procedures is becoming a strong driving force in clinical advancements. This collaborative technological innovation between the two parties is a positive response to this trend and demand.

Zhang Min, Deputy Secretary of the Working Committee and Deputy Director of the Management Committee of Shanghai Jiading Industrial Zone, as well as党委书记and Chairman of the Industrial Zone Group, stated that the collaboration between Medtronic Kanghui and Jinhai Medical is a model of the innovative ecosystem in Jiading Industrial Zone. "We will continue to optimize the business environment, support multinational corporations and local enterprises in closely cooperating across the entire chain of research and development, manufacturing, and commercialization, enhance core competitiveness, and jointly create innovative products with international competitiveness."

Moreover, Medtronic Kanghui has also partnered with GenLight to jointly release the "Robotic-Guided Laser Ablation Minimally Invasive Technology." This technology incorporates Medtronic's Stealth Autoguide.^™Neurosurgical robotics and high-speed power systems are fully integrated with GenLight's LITT (Laser Interstitial Thermal Therapy) system, achieving a deep fusion of global intelligence and Chinese innovation.

Dr. Peng Cao, Chairman of Genlight Neurotech, stated that this joint technology release with Medtronic Kanghui will fully integrate the strengths of both parties in technology and clinical promotion, accelerate the implementation of the LITT system in more medical institutions in China, and promote the availability of this advanced therapy to a wider patient population.